login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock News
USA
- NASDAQ:CRBP -
US21833P3010
-
Common Stock
17.215
USD
+0.09 (+0.55%)
Last: 10/29/2025, 11:47:39 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CRBP Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25
15 days ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
a month ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
a month ago - By: Corbus Pharmaceuticals Holdings, Inc.
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
3 months ago - By: Zacks Investment Research
- Mentions:
CGC
TLRY
HRMY
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
3 months ago - By: The Motley Fool
Corbus (CRBP) Q2 Loss Beats Estimates
3 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
3 months ago - By: Benzinga
- Mentions:
CBDY
CVSI
GNLN
CNBX
...
Cannabis Stock Gainers And Losers From July 16, 2025
4 months ago - By: Benzinga
- Mentions:
IIPR
LBUY
MRMD
SNDL
...
Cannabis Stock Movers For July 15, 2025
4 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
4 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
4 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
5 months ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
SKYE
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
5 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
5 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
6 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference
6 months ago - By: Zacks Investment Research
- Mentions:
TLRY
PM
JAZZ
Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?
6 months ago - By: Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Please enable JavaScript to continue using this application.